Industry Research Reports
Home > Reports > Machinery & Equipment > Global Pharmaceutical Industry Granulator Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Pharmaceutical Industry Granulator Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Machinery & Equipment
Published Date: 2025-08-12
Pages: 203 Pages
Report ld: 4923919
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmaceutical Industry Granulator Market Size(US$)
CAGR 2025-2031
2.8%
Market Size,2031
USD 351
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 297 million
Market Forecast in 2031(Value)
US$ 351 million
CAGR
2.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Industry Granulator market is projected to grow from US$ 284 million in 2024 to US$ 351 million by 2031, at a CAGR of 2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Pharmaceutical Industry Granulator is a specialized machine used to convert fine powder particles into uniform, larger granules through a process known as granulation. This process is essential in pharmaceutical manufacturing, particularly for the production of solid dosage forms such as tablets and capsules. Granulators improve powder flowability, compressibility, and uniformity of active pharmaceutical ingredients (APIs), thereby enhancing the consistency, bioavailability, and quality control of the final product. These machines typically operate using either wet granulation (adding a liquid binder) or dry granulation (compaction without liquid).
The global market for Pharmaceutical Industry Granulator is witnessing consistent growth, driven by rising demand for solid oral dosage forms, especially tablets and capsules, which remain the most preferred delivery method worldwide. Factors such as the growing prevalence of chronic diseases, aging population, expanding generic drug manufacturing, and technological innovation in granulation systems are contributing to the market expansion. High-shear and fluid bed granulators dominate the market due to their ability to produce consistent granule size with higher process efficiency and scalability. Moreover, the push for continuous manufacturing and automation is prompting pharmaceutical companies to upgrade older batch granulation systems to modern, automated granulators with real-time monitoring capabilities.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Industry Granulator market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- AKW
- Syntegon
- DIOSNA
- Caleva
- Thurne
- IMA
- Yenchen
- PerMix
- PTK-GB
- Lodha Machine
- SaintyCo
- FREUND
- Noavaran Industries
- Romaco
- NARA
- HYWELL
- Gansons
- INORA
- Promas Engineers
- Senieer
- GEA Group
- UPMACH
- Riddhi Pharma Machinery
- Jiangnan Pharmaceutical Machinery
- Xianfeng Drying Engineering
- Chin Yi Machinery
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Dry Type
- Wet Type
Segment by Application
- Tablets
- Capsules
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Pharmaceutical Industry Granulator study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pharmaceutical Industry Granulator: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Industry Granulator Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Dry Type
1.2.3 Wet Type
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Industry Granulator Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Industry Granulator Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Industry Granulator Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharmaceutical Industry Granulator Sales Estimates and Forecasts 2020-2031
2.4 Global Pharmaceutical Industry Granulator Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Pharmaceutical Industry Granulator Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Pharmaceutical Industry Granulator Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Pharmaceutical Industry Granulator Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Dry Type Market Size by Manufacturers
4.5.2 Wet Type Market Size by Manufacturers
4.6 Global Pharmaceutical Industry Granulator Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Pharmaceutical Industry Granulator Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Pharmaceutical Industry Granulator Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Pharmaceutical Industry Granulator Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Pharmaceutical Industry Granulator Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Pharmaceutical Industry Granulator Sales and Revenue by Type (2020-2031)
7.4 North America Pharmaceutical Industry Granulator Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Pharmaceutical Industry Granulator Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Pharmaceutical Industry Granulator Sales and Revenue by Type (2020-2031)
8.4 Europe Pharmaceutical Industry Granulator Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Pharmaceutical Industry Granulator Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Pharmaceutical Industry Granulator Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Pharmaceutical Industry Granulator Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Pharmaceutical Industry Granulator Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Pharmaceutical Industry Granulator Sales and Revenue by Type (2020-2031)
10.4 Central and South America Pharmaceutical Industry Granulator Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Pharmaceutical Industry Granulator Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Pharmaceutical Industry Granulator Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Pharmaceutical Industry Granulator Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Pharmaceutical Industry Granulator Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 AKW
12.1.1 AKW Corporation Information
12.1.2 AKW Business Overview
12.1.3 AKW Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.1.4 AKW Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 AKW Pharmaceutical Industry Granulator Sales by Product in 2024
12.1.6 AKW Pharmaceutical Industry Granulator Sales by Application in 2024
12.1.7 AKW Pharmaceutical Industry Granulator Sales by Geographic Area in 2024
12.1.8 AKW Pharmaceutical Industry Granulator SWOT Analysis
12.1.9 AKW Recent Developments
12.2 Syntegon
12.2.1 Syntegon Corporation Information
12.2.2 Syntegon Business Overview
12.2.3 Syntegon Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.2.4 Syntegon Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Syntegon Pharmaceutical Industry Granulator Sales by Product in 2024
12.2.6 Syntegon Pharmaceutical Industry Granulator Sales by Application in 2024
12.2.7 Syntegon Pharmaceutical Industry Granulator Sales by Geographic Area in 2024
12.2.8 Syntegon Pharmaceutical Industry Granulator SWOT Analysis
12.2.9 Syntegon Recent Developments
12.3 DIOSNA
12.3.1 DIOSNA Corporation Information
12.3.2 DIOSNA Business Overview
12.3.3 DIOSNA Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.3.4 DIOSNA Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 DIOSNA Pharmaceutical Industry Granulator Sales by Product in 2024
12.3.6 DIOSNA Pharmaceutical Industry Granulator Sales by Application in 2024
12.3.7 DIOSNA Pharmaceutical Industry Granulator Sales by Geographic Area in 2024
12.3.8 DIOSNA Pharmaceutical Industry Granulator SWOT Analysis
12.3.9 DIOSNA Recent Developments
12.4 Caleva
12.4.1 Caleva Corporation Information
12.4.2 Caleva Business Overview
12.4.3 Caleva Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.4.4 Caleva Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Caleva Pharmaceutical Industry Granulator Sales by Product in 2024
12.4.6 Caleva Pharmaceutical Industry Granulator Sales by Application in 2024
12.4.7 Caleva Pharmaceutical Industry Granulator Sales by Geographic Area in 2024
12.4.8 Caleva Pharmaceutical Industry Granulator SWOT Analysis
12.4.9 Caleva Recent Developments
12.5 Thurne
12.5.1 Thurne Corporation Information
12.5.2 Thurne Business Overview
12.5.3 Thurne Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.5.4 Thurne Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Thurne Pharmaceutical Industry Granulator Sales by Product in 2024
12.5.6 Thurne Pharmaceutical Industry Granulator Sales by Application in 2024
12.5.7 Thurne Pharmaceutical Industry Granulator Sales by Geographic Area in 2024
12.5.8 Thurne Pharmaceutical Industry Granulator SWOT Analysis
12.5.9 Thurne Recent Developments
12.6 IMA
12.6.1 IMA Corporation Information
12.6.2 IMA Business Overview
12.6.3 IMA Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.6.4 IMA Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 IMA Recent Developments
12.7 Yenchen
12.7.1 Yenchen Corporation Information
12.7.2 Yenchen Business Overview
12.7.3 Yenchen Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.7.4 Yenchen Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Yenchen Recent Developments
12.8 PerMix
12.8.1 PerMix Corporation Information
12.8.2 PerMix Business Overview
12.8.3 PerMix Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.8.4 PerMix Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 PerMix Recent Developments
12.9 PTK-GB
12.9.1 PTK-GB Corporation Information
12.9.2 PTK-GB Business Overview
12.9.3 PTK-GB Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.9.4 PTK-GB Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 PTK-GB Recent Developments
12.10 Lodha Machine
12.10.1 Lodha Machine Corporation Information
12.10.2 Lodha Machine Business Overview
12.10.3 Lodha Machine Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.10.4 Lodha Machine Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Lodha Machine Recent Developments
12.11 SaintyCo
12.11.1 SaintyCo Corporation Information
12.11.2 SaintyCo Business Overview
12.11.3 SaintyCo Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.11.4 SaintyCo Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 SaintyCo Recent Developments
12.12 FREUND
12.12.1 FREUND Corporation Information
12.12.2 FREUND Business Overview
12.12.3 FREUND Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.12.4 FREUND Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 FREUND Recent Developments
12.13 Noavaran Industries
12.13.1 Noavaran Industries Corporation Information
12.13.2 Noavaran Industries Business Overview
12.13.3 Noavaran Industries Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.13.4 Noavaran Industries Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Noavaran Industries Recent Developments
12.14 Romaco
12.14.1 Romaco Corporation Information
12.14.2 Romaco Business Overview
12.14.3 Romaco Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.14.4 Romaco Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 Romaco Recent Developments
12.15 NARA
12.15.1 NARA Corporation Information
12.15.2 NARA Business Overview
12.15.3 NARA Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.15.4 NARA Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 NARA Recent Developments
12.16 HYWELL
12.16.1 HYWELL Corporation Information
12.16.2 HYWELL Business Overview
12.16.3 HYWELL Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.16.4 HYWELL Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 HYWELL Recent Developments
12.17 Gansons
12.17.1 Gansons Corporation Information
12.17.2 Gansons Business Overview
12.17.3 Gansons Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.17.4 Gansons Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.17.5 Gansons Recent Developments
12.18 INORA
12.18.1 INORA Corporation Information
12.18.2 INORA Business Overview
12.18.3 INORA Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.18.4 INORA Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.18.5 INORA Recent Developments
12.19 Promas Engineers
12.19.1 Promas Engineers Corporation Information
12.19.2 Promas Engineers Business Overview
12.19.3 Promas Engineers Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.19.4 Promas Engineers Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.19.5 Promas Engineers Recent Developments
12.20 Senieer
12.20.1 Senieer Corporation Information
12.20.2 Senieer Business Overview
12.20.3 Senieer Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.20.4 Senieer Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.20.5 Senieer Recent Developments
12.21 GEA Group
12.21.1 GEA Group Corporation Information
12.21.2 GEA Group Business Overview
12.21.3 GEA Group Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.21.4 GEA Group Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.21.5 GEA Group Recent Developments
12.22 UPMACH
12.22.1 UPMACH Corporation Information
12.22.2 UPMACH Business Overview
12.22.3 UPMACH Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.22.4 UPMACH Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.22.5 UPMACH Recent Developments
12.23 Riddhi Pharma Machinery
12.23.1 Riddhi Pharma Machinery Corporation Information
12.23.2 Riddhi Pharma Machinery Business Overview
12.23.3 Riddhi Pharma Machinery Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.23.4 Riddhi Pharma Machinery Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.23.5 Riddhi Pharma Machinery Recent Developments
12.24 Jiangnan Pharmaceutical Machinery
12.24.1 Jiangnan Pharmaceutical Machinery Corporation Information
12.24.2 Jiangnan Pharmaceutical Machinery Business Overview
12.24.3 Jiangnan Pharmaceutical Machinery Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.24.4 Jiangnan Pharmaceutical Machinery Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.24.5 Jiangnan Pharmaceutical Machinery Recent Developments
12.25 Xianfeng Drying Engineering
12.25.1 Xianfeng Drying Engineering Corporation Information
12.25.2 Xianfeng Drying Engineering Business Overview
12.25.3 Xianfeng Drying Engineering Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.25.4 Xianfeng Drying Engineering Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.25.5 Xianfeng Drying Engineering Recent Developments
12.26 Chin Yi Machinery
12.26.1 Chin Yi Machinery Corporation Information
12.26.2 Chin Yi Machinery Business Overview
12.26.3 Chin Yi Machinery Pharmaceutical Industry Granulator Product Models, Descriptions and Specifications
12.26.4 Chin Yi Machinery Pharmaceutical Industry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.26.5 Chin Yi Machinery Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Pharmaceutical Industry Granulator Industry Chain
13.2 Pharmaceutical Industry Granulator Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Pharmaceutical Industry Granulator Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Pharmaceutical Industry Granulator Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Pharmaceutical Industry Granulator Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Pharmaceutical Industry Granulator Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Industry Granulator Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Industry Granulator Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Industry Granulator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Industry Granulator Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Industry Granulator Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Pharmaceutical Industry Granulator Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Pharmaceutical Industry Granulator Sales by Region (2020-2025) & (Units)
Table 8. Global Pharmaceutical Industry Granulator Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Pharmaceutical Industry Granulator Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 11. Global Pharmaceutical Industry Granulator Production by Region (2020-2025) & (Units)
Table 12. Global Pharmaceutical Industry Granulator Production by Region (2026-2031) & (Units)
Table 13. Global Pharmaceutical Industry Granulator Sales by Manufacturers (2020-2025) & (Units)
Table 14. Global Pharmaceutical Industry Granulator Sales Share by Manufacturers (2020-2025)
Table 15. Global Pharmaceutical Industry Granulator Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Pharmaceutical Industry Granulator Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Pharmaceutical Industry Granulator by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Industry Granulator as of 2024)
Table 19. Global Pharmaceutical Industry Granulator Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Pharmaceutical Industry Granulator Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Pharmaceutical Industry Granulator Manufacturing Base and Headquarters
Table 22. Global Pharmaceutical Industry Granulator Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Pharmaceutical Industry Granulator Sales by Type (2020-2025) & (Units)
Table 26. Global Pharmaceutical Industry Granulator Sales by Type (2026-2031) & (Units)
Table 27. Global Pharmaceutical Industry Granulator Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Pharmaceutical Industry Granulator Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Pharmaceutical Industry Granulator ASP by Type (2020-2031) & (US$/Unit)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Pharmaceutical Industry Granulator Sales by Application (2020-2025) & (Units)
Table 32. Global Pharmaceutical Industry Granulator Sales by Application (2026-2031) & (Units)
Table 33. Pharmaceutical Industry Granulator High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Pharmaceutical Industry Granulator Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Pharmaceutical Industry Granulator Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Pharmaceutical Industry Granulator ASP by Application (2020-2031) & (US$/Unit)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Pharmaceutical Industry Granulator Growth Accelerators and Market Barriers
Table 40. North America Pharmaceutical Industry Granulator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Pharmaceutical Industry Granulator Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Pharmaceutical Industry Granulator Growth Accelerators and Market Barriers
Table 43. Europe Pharmaceutical Industry Granulator Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Pharmaceutical Industry Granulator Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Pharmaceutical Industry Granulator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Pharmaceutical Industry Granulator Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Pharmaceutical Industry Granulator Growth Accelerators and Market Barriers
Table 48. Southeast Asia Pharmaceutical Industry Granulator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Pharmaceutical Industry Granulator Investment Opportunities and Key Challenges
Table 50. Central and South America Pharmaceutical Industry Granulator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Pharmaceutical Industry Granulator Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Pharmaceutical Industry Granulator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. AKW Corporation Information
Table 54. AKW Description and Major Businesses
Table 55. AKW Product Models, Descriptions and Specifications
Table 56. AKW Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 57. AKW Sales Value Proportion by Product in 2024
Table 58. AKW Sales Value Proportion by Application in 2024
Table 59. AKW Sales Value Proportion by Geographic Area in 2024
Table 60. AKW Pharmaceutical Industry Granulator SWOT Analysis
Table 61. AKW Recent Developments
Table 62. Syntegon Corporation Information
Table 63. Syntegon Description and Major Businesses
Table 64. Syntegon Product Models, Descriptions and Specifications
Table 65. Syntegon Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 66. Syntegon Sales Value Proportion by Product in 2024
Table 67. Syntegon Sales Value Proportion by Application in 2024
Table 68. Syntegon Sales Value Proportion by Geographic Area in 2024
Table 69. Syntegon Pharmaceutical Industry Granulator SWOT Analysis
Table 70. Syntegon Recent Developments
Table 71. DIOSNA Corporation Information
Table 72. DIOSNA Description and Major Businesses
Table 73. DIOSNA Product Models, Descriptions and Specifications
Table 74. DIOSNA Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. DIOSNA Sales Value Proportion by Product in 2024
Table 76. DIOSNA Sales Value Proportion by Application in 2024
Table 77. DIOSNA Sales Value Proportion by Geographic Area in 2024
Table 78. DIOSNA Pharmaceutical Industry Granulator SWOT Analysis
Table 79. DIOSNA Recent Developments
Table 80. Caleva Corporation Information
Table 81. Caleva Description and Major Businesses
Table 82. Caleva Product Models, Descriptions and Specifications
Table 83. Caleva Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. Caleva Sales Value Proportion by Product in 2024
Table 85. Caleva Sales Value Proportion by Application in 2024
Table 86. Caleva Sales Value Proportion by Geographic Area in 2024
Table 87. Caleva Pharmaceutical Industry Granulator SWOT Analysis
Table 88. Caleva Recent Developments
Table 89. Thurne Corporation Information
Table 90. Thurne Description and Major Businesses
Table 91. Thurne Product Models, Descriptions and Specifications
Table 92. Thurne Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Thurne Sales Value Proportion by Product in 2024
Table 94. Thurne Sales Value Proportion by Application in 2024
Table 95. Thurne Sales Value Proportion by Geographic Area in 2024
Table 96. Thurne Pharmaceutical Industry Granulator SWOT Analysis
Table 97. Thurne Recent Developments
Table 98. IMA Corporation Information
Table 99. IMA Description and Major Businesses
Table 100. IMA Product Models, Descriptions and Specifications
Table 101. IMA Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. IMA Recent Developments
Table 103. Yenchen Corporation Information
Table 104. Yenchen Description and Major Businesses
Table 105. Yenchen Product Models, Descriptions and Specifications
Table 106. Yenchen Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. Yenchen Recent Developments
Table 108. PerMix Corporation Information
Table 109. PerMix Description and Major Businesses
Table 110. PerMix Product Models, Descriptions and Specifications
Table 111. PerMix Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. PerMix Recent Developments
Table 113. PTK-GB Corporation Information
Table 114. PTK-GB Description and Major Businesses
Table 115. PTK-GB Product Models, Descriptions and Specifications
Table 116. PTK-GB Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 117. PTK-GB Recent Developments
Table 118. Lodha Machine Corporation Information
Table 119. Lodha Machine Description and Major Businesses
Table 120. Lodha Machine Product Models, Descriptions and Specifications
Table 121. Lodha Machine Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 122. Lodha Machine Recent Developments
Table 123. SaintyCo Corporation Information
Table 124. SaintyCo Description and Major Businesses
Table 125. SaintyCo Product Models, Descriptions and Specifications
Table 126. SaintyCo Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 127. SaintyCo Recent Developments
Table 128. FREUND Corporation Information
Table 129. FREUND Description and Major Businesses
Table 130. FREUND Product Models, Descriptions and Specifications
Table 131. FREUND Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 132. FREUND Recent Developments
Table 133. Noavaran Industries Corporation Information
Table 134. Noavaran Industries Description and Major Businesses
Table 135. Noavaran Industries Product Models, Descriptions and Specifications
Table 136. Noavaran Industries Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 137. Noavaran Industries Recent Developments
Table 138. Romaco Corporation Information
Table 139. Romaco Description and Major Businesses
Table 140. Romaco Product Models, Descriptions and Specifications
Table 141. Romaco Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 142. Romaco Recent Developments
Table 143. NARA Corporation Information
Table 144. NARA Description and Major Businesses
Table 145. NARA Product Models, Descriptions and Specifications
Table 146. NARA Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 147. NARA Recent Developments
Table 148. HYWELL Corporation Information
Table 149. HYWELL Description and Major Businesses
Table 150. HYWELL Product Models, Descriptions and Specifications
Table 151. HYWELL Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 152. HYWELL Recent Developments
Table 153. Gansons Corporation Information
Table 154. Gansons Description and Major Businesses
Table 155. Gansons Product Models, Descriptions and Specifications
Table 156. Gansons Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 157. Gansons Recent Developments
Table 158. INORA Corporation Information
Table 159. INORA Description and Major Businesses
Table 160. INORA Product Models, Descriptions and Specifications
Table 161. INORA Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 162. INORA Recent Developments
Table 163. Promas Engineers Corporation Information
Table 164. Promas Engineers Description and Major Businesses
Table 165. Promas Engineers Product Models, Descriptions and Specifications
Table 166. Promas Engineers Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 167. Promas Engineers Recent Developments
Table 168. Senieer Corporation Information
Table 169. Senieer Description and Major Businesses
Table 170. Senieer Product Models, Descriptions and Specifications
Table 171. Senieer Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 172. Senieer Recent Developments
Table 173. GEA Group Corporation Information
Table 174. GEA Group Description and Major Businesses
Table 175. GEA Group Product Models, Descriptions and Specifications
Table 176. GEA Group Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 177. GEA Group Recent Developments
Table 178. UPMACH Corporation Information
Table 179. UPMACH Description and Major Businesses
Table 180. UPMACH Product Models, Descriptions and Specifications
Table 181. UPMACH Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 182. UPMACH Recent Developments
Table 183. Riddhi Pharma Machinery Corporation Information
Table 184. Riddhi Pharma Machinery Description and Major Businesses
Table 185. Riddhi Pharma Machinery Product Models, Descriptions and Specifications
Table 186. Riddhi Pharma Machinery Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 187. Riddhi Pharma Machinery Recent Developments
Table 188. Jiangnan Pharmaceutical Machinery Corporation Information
Table 189. Jiangnan Pharmaceutical Machinery Description and Major Businesses
Table 190. Jiangnan Pharmaceutical Machinery Product Models, Descriptions and Specifications
Table 191. Jiangnan Pharmaceutical Machinery Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 192. Jiangnan Pharmaceutical Machinery Recent Developments
Table 193. Xianfeng Drying Engineering Corporation Information
Table 194. Xianfeng Drying Engineering Description and Major Businesses
Table 195. Xianfeng Drying Engineering Product Models, Descriptions and Specifications
Table 196. Xianfeng Drying Engineering Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 197. Xianfeng Drying Engineering Recent Developments
Table 198. Chin Yi Machinery Corporation Information
Table 199. Chin Yi Machinery Description and Major Businesses
Table 200. Chin Yi Machinery Product Models, Descriptions and Specifications
Table 201. Chin Yi Machinery Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 202. Chin Yi Machinery Recent Developments
Table 203. Key Raw Materials Distribution
Table 204. Raw Materials Key Suppliers
Table 205. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 206. Milestones in Production Technology Evolution
Table 207. Distributors List
Table 208. Market Trends and Market Evolution
Table 209. Market Drivers and Opportunities
Table 210. Market Challenges, Risks, and Restraints
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Industry Granulator Product Picture
Figure 2. Global Pharmaceutical Industry Granulator Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Dry Type Product Picture
Figure 4. Wet Type Product Picture
Figure 5. Global Pharmaceutical Industry Granulator Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Tablets
Figure 7. Capsules
Figure 8. Others
Figure 9. Pharmaceutical Industry Granulator Report Years Considered
Figure 10. Global Pharmaceutical Industry Granulator Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 12. Global Pharmaceutical Industry Granulator Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Pharmaceutical Industry Granulator Revenue Market Share by Region (2020-2031)
Figure 14. Global Pharmaceutical Industry Granulator Sales (2020-2031) & (Units)
Figure 15. Global Pharmaceutical Industry Granulator Sales (CAGR) by Region (2020-2031) (Units)
Figure 16. Global Pharmaceutical Industry Granulator Sales Market Share by Region (2020-2031)
Figure 17. Global Pharmaceutical Industry Granulator Capacity, Production and Utilization (2020-2031) & (Units)
Figure 18. Global Pharmaceutical Industry Granulator Production Trend by Region (2020-2031) (Units)
Figure 19. Global Pharmaceutical Industry Granulator Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Pharmaceutical Industry Granulator Production Growth Rate in North America (2020-2031) & (Units)
Figure 22. Pharmaceutical Industry Granulator Production Growth Rate in Europe (2020-2031) & (Units)
Figure 23. Pharmaceutical Industry Granulator Production Growth Rate in China (2020-2031) & (Units)
Figure 24. Pharmaceutical Industry Granulator Production Growth Rate in Japan (2020-2031) & (Units)
Figure 25. Top 5 and Top 10 Manufacturers Pharmaceutical Industry Granulator Sales Volume Market Share in 2024
Figure 26. Global Pharmaceutical Industry Granulator Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. Dry Type Revenue Market Share by Manufacturer in 2024
Figure 29. Wet Type Revenue Market Share by Manufacturer in 2024
Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 32. Global Pharmaceutical Industry Granulator Sales Market Share by Type (2020-2031)
Figure 33. Global Pharmaceutical Industry Granulator Revenue Market Share by Type (2020-2031)
Figure 34. Global Pharmaceutical Industry Granulator Sales Market Share by Application (2020-2031)
Figure 35. Global Pharmaceutical Industry Granulator Revenue Market Share by Application (2020-2031)
Figure 36. North America Pharmaceutical Industry Granulator Sales YoY (2020-2031) & (Units)
Figure 37. North America Pharmaceutical Industry Granulator Revenue YoY (2020-2031) & (US$ Million)
Figure 38. North America Top 5 Manufacturers Pharmaceutical Industry Granulator Sales Revenue (US$ Million) in 2024
Figure 39. North America Pharmaceutical Industry Granulator Sales Volume (Units) by Type (2020- 2031)
Figure 40. North America Pharmaceutical Industry Granulator Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 41. North America Pharmaceutical Industry Granulator Sales Volume (Units) by Application (2020-2031)
Figure 42. North America Pharmaceutical Industry Granulator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. US Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 44. Canada Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 45. Mexico Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Pharmaceutical Industry Granulator Sales YoY (2020-2031) & (Units)
Figure 47. Europe Pharmaceutical Industry Granulator Revenue YoY (2020-2031) & (US$ Million)
Figure 48. Europe Top 5 Manufacturers Pharmaceutical Industry Granulator Sales Revenue (US$ Million) in 2024
Figure 49. Europe Pharmaceutical Industry Granulator Sales Volume (Units) by Type (2020-2031)
Figure 50. Europe Pharmaceutical Industry Granulator Sales Revenue (US$ Million) by Type (2020-2031)
Figure 51. Europe Pharmaceutical Industry Granulator Sales Volume (Units) by Application (2020-2031)
Figure 52. Europe Pharmaceutical Industry Granulator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 53. Germany Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 54. France Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 55. U.K. Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 56. Italy Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 57. Russia Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Pharmaceutical Industry Granulator Sales YoY (2020-2031) & (Units)
Figure 59. Asia-Pacific Pharmaceutical Industry Granulator Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Top 8 Manufacturers Pharmaceutical Industry Granulator Sales Revenue (US$ Million) in 2024
Figure 61. Asia-Pacific Pharmaceutical Industry Granulator Sales Volume (Units) by Type (2020- 2031)
Figure 62. Asia-Pacific Pharmaceutical Industry Granulator Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 63. Asia-Pacific Pharmaceutical Industry Granulator Sales Volume (Units) by Application (2020-2031)
Figure 64. Asia-Pacific Pharmaceutical Industry Granulator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 65. Indonesia Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 66. Japan Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 67. South Korea Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 68. China Taiwan Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 69. India Pharmaceutical Industry Granulator Revenue (2020-2031) & (US$ Million)
Figure 70. Central and South America Pharmaceutical Industry Granulator Sales YoY (2020-2031) & (Units)
Figure 71. Central and South America Pharmaceutical Industry Granulator Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Central and South America Top 5 Manufacturers Pharmaceutical Industry Granulator Sales Revenue (US$ Million) in 2024
Figure 73. Central and South America Pharmaceutical Industry Granulator Sales Volume (Units) by Type (2021-2031)
Figure 74. Central and South America Pharmaceutical Industry Granulator Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Central and South America Pharmaceutical Industry Granulator Sales Volume (Units) by Application (2020-2031)
Figure 76. Central and South America Pharmaceutical Industry Granulator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. Brazil Pharmaceutical Industry Granulator Revenue (2020-2025) & (US$ Million)
Figure 78. Argentina Pharmaceutical Industry Granulator Revenue (2020-2025) & (US$ Million)
Figure 79. Middle East, and Africa Pharmaceutical Industry Granulator Sales YoY (2020-2031) & (Units)
Figure 80. Middle East and Africa Pharmaceutical Industry Granulator Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Middle East and Africa Top 5 Manufacturers Pharmaceutical Industry Granulator Sales Revenue (US$ Million) in 2024
Figure 82. Middle East and Africa Pharmaceutical Industry Granulator Sales Volume (Units) by Type (2021-2031)
Figure 83. South America Pharmaceutical Industry Granulator Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Middle East and Africa Pharmaceutical Industry Granulator Sales Volume (Units) by Application (2020-2031)
Figure 85. Middle East and Africa Pharmaceutical Industry Granulator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. GCC Countries Pharmaceutical Industry Granulator Revenue (2020-2025) & (US$ Million)
Figure 87. Turkey Pharmaceutical Industry Granulator Revenue (2020-2025) & (US$ Million)
Figure 88. Egypt Pharmaceutical Industry Granulator Revenue (2020-2025) & (US$ Million)
Figure 89. South Africa Pharmaceutical Industry Granulator Revenue (2020-2025) & (US$ Million)
Figure 90. Pharmaceutical Industry Granulator Industry Chain Mapping
Figure 91. Regional Pharmaceutical Industry Granulator Manufacturing Base Distribution (%)
Figure 92. Pharmaceutical Industry Granulator Production Process
Figure 93. Regional Pharmaceutical Industry Granulator Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pharmaceutical Industry Granulator market?
The top companies in the global Pharmaceutical Industry Granulator market are AKW、Syntegon、DIOSNA.
What was the global market size of Pharmaceutical Industry Granulator in 2025?
What is the annual compound growth rate of the global Pharmaceutical Industry Granulator market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Pharmaceutical Industry Granulator in 2031?
Related Reports
Pharmaceutical Industry Granulator- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Industry Granulator was estimated to be worth US$ 297 million in 2025 and is projected to reach US$ 360 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-02-14
Pages: 172
USD 3950.00
(Single User License)
Global Pharmaceutical Industry Granulator Market Research Report 2026
The global Pharmaceutical Industry Granulator market was valued at US$ 297 million in 2025 and is anticipated to reach US$ 360 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-02-14
Pages: 169
USD 2900.00
(Single User License)
Global Pharmaceutical Industry Granulator Market Research Report 2025
The global market for Pharmaceutical Industry Granulator was valued at US$ 284 million in the year 2024 and is projected to reach a revised size of US$ 351 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published Date: 2025-08-12
Pages: 130
USD 2900.00
(Single User License)
Pharmaceutical Industry Granulator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Industry Granulator was estimated to be worth US$ 284 million in 2024 and is forecast to a readjusted size of US$ 351 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-08-12
Pages: 177
USD 3950.00
(Single User License)
Global Pharmaceutical Industry Granulator Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Industry Granulator market size was US$ 284 million in 2024 and is forecast to a readjusted size of US$ 351 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-08-12
Pages: 129
USD 4250.00
(Single User License)
Global Pharmaceutical Industry Granulator Market Insights, Forecast to 2030
The global Pharmaceutical Industry Granulator market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-26
Pages: 115
USD 4900.00
(Single User License)
Pharmaceutical Industry Granulator- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Industry Granulator was estimated to be worth US$ 297 million in 2025 and is projected to reach US$ 360 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-02-14
Pages: 172
USD 3950.00 (Single User License)Global Pharmaceutical Industry Granulator Market Research Report 2026
The global Pharmaceutical Industry Granulator market was valued at US$ 297 million in 2025 and is anticipated to reach US$ 360 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-02-14
Pages: 169
USD 2900.00 (Single User License)Global Pharmaceutical Industry Granulator Market Research Report 2025
The global market for Pharmaceutical Industry Granulator was valued at US$ 284 million in the year 2024 and is projected to reach a revised size of US$ 351 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published: 2025-08-12
Pages: 130
USD 2900.00 (Single User License)Pharmaceutical Industry Granulator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Industry Granulator was estimated to be worth US$ 284 million in 2024 and is forecast to a readjusted size of US$ 351 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-08-12
Pages: 177
USD 3950.00 (Single User License)Global Pharmaceutical Industry Granulator Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Industry Granulator market size was US$ 284 million in 2024 and is forecast to a readjusted size of US$ 351 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-08-12
Pages: 129
USD 4250.00 (Single User License)Global Pharmaceutical Industry Granulator Market Insights, Forecast to 2030
The global Pharmaceutical Industry Granulator market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-26
Pages: 115
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now